Latest News and Press Releases

As per the report by Visiongain, the Nasal Drug Delivery Technology Market was valued at US$71.0 billion in 2022 and is projected to grow at a CAGR of 7.5% during the forecast period 2023-2033.  ...

As per the report by Visiongain, the Menopause Market was valued at US$17.33 million in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period 2023-2033.  Visiongain has...

Visiongain has published a new report entitled Nasal Drug Delivery Technology 2023-2033: Forecasts by Containers (Pressurized Containers, Non-pressurized Containers), by System (Nasal Bi Dose, Nasal...

Visiongain has published a new report entitled Nasal Drug Delivery Technology 2023-2033: Forecasts by Containers (Pressurized Containers, Non-pressurized Containers), by System (Nasal Bi Dose, Nasal...

Visiongain has published a new report: Gynaecology Drugs Market, (COVID-19 Impact Analysis):- Market Segment by Disease (Gynaecology Cancers, Contraception, Female Infertility, Menopausal Disorders,...

Visiongain has published a new report: Gynaecology Drugs Market, (COVID-19 Impact Analysis):- Market Segment by Disease (Gynaecology Cancers, Contraception, Female Infertility, Menopausal Disorders,...

Visiongain has published a new report entitled Meningococcal Vaccines 2023-2033. It includes profiles of Meningococcal Vaccines and Forecasts Market Segment by Vaccine Type (Conjugate,...

Visiongain has published a new report: Gynaecology Drugs Market, (COVID-19 Impact Analysis):- Market Segment by Disease (Gynaecology Cancers, Contraception, Female Infertility, Menopausal Disorders,...

Market Segment by Type (mRNA Prophylactic Vaccines, Therapeutics Vaccines, mRNA Therapeutics), Market Segment by Vector (Self-amplifying, Non-amplifying mRNA), Market Segment by Vector Platforms...

Visiongain has published a new report on “Rare Disease Market Forecast 2021-2031: By Drugs (Revlimid, MabThera/Rituxan, Opdivo, Imbruvica, Sprycel, Tasigna, Copaxone,Rebif, Gleevec, Velcade, Others),...